LakePharma
LakePharma is a biologics CRDMO providing integrated antibody discovery, cell line development, process development, and GMP manufacturing services, now operating within Curia Global's biologics division serving biotech and pharma developers.
- Company typePrivate
- Founded2009
- HeadquartersBelmont, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What LakePharma does
LakePharma is a biologics Contract Research, Development, and Manufacturing Organization (CRDMO) that provides integrated services from target discovery through engineering, process development, and GMP manufacturing. Founded in 2009 by Hua Tu and headquartered in Belmont, California, the company built its platform around antibody discovery and engineering, recombinant protein and antibody production, cell line development, upstream and downstream process development, and GMP drug substance manufacturing using mammalian, mRNA, and Baculovirus Expression Vector System (BEVS) modalities. Its discovery capabilities include molecular biology, cell engineering, bioanalytical assays, and biological and functional assays, while its development and manufacturing footprint covers cell line development, mRNA process and analytical services, LNP formulation, GMP mammalian and mRNA drug substance manufacturing, analytical testing and release, quality systems, and biorepository services.
The business operates as a B2B fee-for-service CRDMO serving biotech and pharmaceutical developers, monetizing through project-based contracts spanning discovery programs, process development work, and GMP manufacturing campaigns. Following a $30 million funding round in December 2017 led by Summit Partners with participation from Ampersand Capital Partners, the company expanded capabilities both organically and through the March 2016 acquisition of Blue Sky Biotech. LakePharma is now operated within Curia Global, Inc., with the combined biologics offering delivered through the curiaglobal.com biologics division, giving customers access to a broader small molecule, sterile drug product, and analytical testing portfolio alongside the legacy LakePharma biologics stack. Leadership comprises founder/CEO Hua Tu, Chief Scientific Officer Norm Garceau, and CFO Dave Boyle.
LakePharma firmographics
Firmographics- Name
- LakePharma
- Website
- https://lakepharma.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- LakePharma is a biologics CRDMO providing integrated antibody discovery, cell line development, process development, and GMP manufacturing services, now operating within Curia Global's biologics division serving biotech and pharma developers.
- Ownership category
- akta.pro rank
LakePharma industry classification
Industry- Product category
- Biologics Contract Development and Manufacturing Services (CRDMO)
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Process Development & Tech Transfer (Upstream/Downstream/MSAT) (HLAGAGAE)
- akta.pro secondary industries
- GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification) (HLAGAGAL), mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC), Cell Banking & Viral Seed Services (MCB/WCB/VSB) (HLAGAGAD), Process Development & Tech Transfer Services (upstream/downstream) (HLAAAKAF), CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)
Keywords
Where LakePharma is headquartered
LocationHeadquarters
- HQ city
- Belmont
- HQ country
- United States
- HQ region
- North America
Markets served
LakePharma business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
LakePharma product offering
Product offeringCore offering
LakePharma is a biologics CRDMO that provides integrated solutions spanning antibody discovery and engineering, recombinant protein and antibody production, mammalian and mRNA process development, cell line development, LNP formulation, and GMP drug substance and sterile drug product manufacturing. Services are sold to biotech and pharmaceutical developers on a contracted, project-by-project basis, with supporting analytical testing, bioanalytical assays, and quality/release systems. The company is presented under the Curia Global brand, extending the offering into small molecule discovery, development, and generic API supply.
Differentiator
Problem solved
Functional benefit
Products and services
- Biologics Discovery Services
- Biologics Development Services Process development services for mammalian biologics (cell line development, upstream and downstream process development), mRNA (DNA services, mRNA process development, mRNA analytical services), and BEVS-based production, supporting IND-enabling development for biologic and nucleic acid programs.
- Biologics GMP Manufacturing GMP manufacturing services for mammalian drug substance, mRNA, and LNP-formulated nucleic acid drug substance, supported by analytical testing and release, quality systems, and biorepository services for clinical and commercial supply.
- Sterile Drug Product Manufacturing Drug product development (formulation and process development), clinical manufacturing, and commercial manufacturing of sterile biologics drug product for biotech and pharma clients.
- Analytical Testing Services Analytical testing services including batch release and stability testing, method development and validation, and solid state chemistry, sold to biologic and small molecule developers.
Companies that use LakePharma
Customer profileIdeal customer profiles2 records
LakePharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
LakePharma partnerships and signals
Strategic signalRecent moves5 records
Expansion highlights5 records
LakePharma competitors and assessment
Company assessmentDirect peers
- Catalent: Major global biologics CDMO offering cell line development, process development, and GMP manufacturing for mAbs and newer modalities. Directly comparable to LakePharma's biologics CRDMO scope, but at significantly larger scale.
- Samsung Biologics: Large-scale mammalian biologics CDMO providing cell line development, process development, and commercial GMP manufacturing. Comparable end-to-end biologics service offering, with substantially greater production capacity.
- Lonza: Global leader in biologics CDMO services spanning mammalian cell line development, upstream/downstream process development, and GMP manufacturing. Closely aligned with LakePharma's integrated CRDMO value proposition.
- WuXi Biologics: Full-service biologics CRDMO offering discovery, development, and GMP manufacturing globally. Direct competitor across LakePharma's antibody discovery, cell line, and GMP mammalian service lines.
- AGC Biologics: Mammalian and microbial biologics CDMO with cell line development, process development, and GMP manufacturing services. Highly comparable mid-to-large scale peer for LakePharma's integrated offering.
- Rentschler Biopharma: European-headquartered biologics CDMO offering cell line development, process development, and GMP manufacturing of mAbs and recombinant proteins. Comparable CRDMO model to LakePharma with similar mid-market positioning.
- Abzena: Biologics CDMO focused on antibody discovery, cell line development, process development, and GMP manufacturing. Closely overlaps LakePharma's discovery-to-development offering, with comparable size.
- Aldevron: Biologics services provider specializing in plasmid DNA, mRNA, and protein production for therapeutic developers. Comparable emerging-modality capabilities (mRNA, nucleic acids) to LakePharma's biologics services.
Broad incumbents
- BioReliance (Merck KGaA): Merck KGaA's biologics testing, validation, and manufacturing services arm. Overlaps with LakePharma's analytical testing, validation, and biomanufacturing support functions within a much broader life-sciences portfolio.
- Curia Global: Acquirer/parent platform of LakePharma offering small molecule, sterile fill-finish, and biologics services. Directly comparable biologics CDMO capabilities with broader small-molecule and sterile DP reach.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
LakePharma social profiles
Digital presenceLakePharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
LakePharma leadership team
Management profileNumber of profiles
Profiles3 records
LakePharma funding detail
Funding detailFunding overview
Funding rounds1 record
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
LakePharma M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about LakePharma
What does LakePharma do?
LakePharma is a biologics CRDMO that provides integrated solutions spanning antibody discovery and engineering, recombinant protein and antibody production, mammalian and mRNA process development, cell line development, LNP formulation, and GMP drug substance and sterile drug product manufacturing. Services are sold to biotech and pharmaceutical developers on a contracted, project-by-project basis, with supporting analytical testing, bioanalytical assays, and quality/release systems. The company is presented under the Curia Global brand, extending the offering into small molecule discovery, development, and generic API supply.
When was LakePharma founded?
LakePharma was founded in 2009. It employs 101 to 250 people.
Where is LakePharma based?
LakePharma is headquartered in Belmont, United States, in the North America region.
Who are LakePharma's main competitors?
Direct peers on record are Catalent, Samsung Biologics, Lonza, WuXi Biologics, AGC Biologics, Rentschler Biopharma, Abzena and Aldevron. Broad incumbents are BioReliance (Merck KGaA) and Curia Global.
Does LakePharma have an API?
No public API is recorded for LakePharma.
What industry is LakePharma in?
LakePharma's product category is Biologics Contract Development and Manufacturing Services (CRDMO). Its primary akta.pro industry code is HLAGAGAE, Process Development & Tech Transfer (Upstream/Downstream/MSAT), with a secondary code of HLAGAGAL, GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification). Its NAICS code is 541714 and its SIC code is 8731.